AC Immune S.A. (ACIU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 171,609 | 194,845 | 159,967 | 126,404 | 154,539 |
| Marketable Securities | 69,329 | 95,618 | 30,672 | N/A | N/A |
| Receivables | 351 | 306 | 445 | 933 | 525 |
| Other current assets | 1,697 | 1,102 | 3,749 | 2,845 | 903 |
| TOTAL | $247,203 | $294,677 | $197,250 | $131,645 | $157,264 |
| Non-Current Assets | |||||
| PPE Net | 4,710 | 3,943 | 3,399 | 2,391 | 1,137 |
| Investments And Advances | 356 | 306 | 311 | 128 | 87 |
| Other Non-Current Assets | 2,371 | 2,270 | 0 | 0 | 0 |
| TOTAL | $7,437 | $6,518 | $3,709 | $2,519 | $1,225 |
| Total Assets | $254,640 | $301,195 | $200,959 | $134,165 | $158,488 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 656 | 339 | N/A | N/A |
| Accounts payable and accrued liabilities | 2,330 | 143 | 2,023 | 1,110 | 4,097 |
| Accrued Expenses | 11,823 | 11,874 | 10,653 | 8,442 | 5,448 |
| TOTAL | $14,952 | $17,624 | $13,375 | $9,913 | $10,074 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 326 | 4,506 | 359 | 361 | 529 |
| Other Non-Current Liabilities | 9,860 | 9,358 | 5,792 | 5,107 | 3,856 |
| TOTAL | $9,860 | $9,358 | $5,982 | $5,508 | $3,856 |
| Total Liabilities | $24,811 | $26,982 | $19,357 | $15,421 | $13,930 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | N/A | N/A | 56,773 |
| Common Shares | 1,640 | 1,446 | 1,381 | 1,166 | 1,152 |
| Retained earnings | -141,698 | -76,012 | -124,607 | -73,791 | -47,639 |
| Other shareholders' equity | -107 | 0 | 0 | 0 | 0 |
| TOTAL | $229,829 | $274,213 | $181,602 | $118,744 | $144,558 |
| Total Liabilities And Equity | $254,640 | $301,195 | $200,959 | $134,165 | $158,488 |